Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks slip on Evergrande woes, weak German business morale

Fri, 24th Sep 2021 09:46

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Friday's declines cut Europe's weekly gains

* Germans head to vote on Sunday

* Adidas, Puma slide after Nike warning
(Adds comments, updates prices throughout)

By Sruthi Shankar and Shreyashi Sanyal

Sept 24 (Reuters) - European stocks fell on Friday as
worries about troubled property developer China Evergrande and
weak German business confidence data prompted investors to book
some profits after a mid-week rally.

European sportswear makers Adidas, Puma
and JD Sports fell about 3% each after U.S. rival Nike
cut its fiscal 2022 sales expectations and predicted
delays during the holiday shopping season due to a supply chain
crunch.

Retail stocks were the top decliners in Europe, down
1.7%, while the region-wide STOXX 600 fell 0.9%. But a
three-day rally put the index 0.3% higher for the week.

"Equities have rallied to take a pause early this morning
faced with the likely default of Evergrande," said Sebastien
Galy, senior macro strategist at Nordea Asset Management.

Investor worries over Evergrande resurfaced as a
deadline for paying $83.5 million in bond interest passed
without remark from the company, putting it closer to a
potential default.

Meanwhile, a survey by Ifo Institute showed German business
morale in September fell for a third straight month, hit by
supply chain woes that are causing a "bottleneck recession" for
manufacturers in Europe's largest economy.

Germany's DAX fell 0.7%, heading into the weekend
when the country will vote to elect German Chancellor Angela
Merkel's successor.

Latest polls showed the Social Democrats were clinging to a
narrow lead over the conservative CDU/CSU alliance, while the
Greens trailed.

"Some of the hesitancy in European markets could also be put
down to the German elections, which promise to be the most
interesting in some time," said Chris Beauchamp, chief market
analyst at IG.

"Markets are facing a change of direction in Germany unlike
anything seen in the past decade or more, and the end of
Merkel's tenure promises to be a watershed moment for the EU and
global investors alike."

The benchmark STOXX 600 is on course to end September in the
red after seven consecutive months of gains as rising energy
prices and supply-chain bottlenecks fed into fears of inflation,
while major central banks plan to cut pandemic-era stimulus.

However, European Central Bank President Christine Lagarde
said in an interview aired on CNBC that many of the drivers of a
recent spike in euro zone inflation are temporary and could fade
in the next year.

British drugmaker AstraZeneca rose 2.0% after the
company said its cancer drug Lynparza met its primary goal in a
late-stage trial.

Italy's utilities Enel and Eni inched
higher after the government set aside more than 3 billion euros
($3.5 billion) to curb a strong increase in retail energy bills.
(Reporting by Sruthi Shankar and Shreyashi Sanyal in Bengaluru;
Editing by Arun Koyyur and Steve Orlofsky)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.